GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » Stock Based Compensation

Intravenous Infusions (XGHA:IIL) Stock Based Compensation : GHS0.00 Mil (TTM As of . 20)


View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions Stock Based Compensation?

Intravenous Infusions's Stock Based Compensation for the six months ended in . 20 was GHS0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in . 20 was GHS0.00 Mil.


Intravenous Infusions Stock Based Compensation Historical Data

The historical data trend for Intravenous Infusions's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions Stock Based Compensation Chart

Intravenous Infusions Annual Data
Trend
Stock Based Compensation

Intravenous Infusions Semi-Annual Data
Stock Based Compensation

Intravenous Infusions Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Stock Based Compensation for the trailing twelve months (TTM) ended in . 20 was GHS0.00 Mil.


Intravenous Infusions Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Intravenous Infusions (XGHA:IIL) Business Description

Traded in Other Exchanges
N/A
Address
Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.